|
Efficacy and safety of olaparib according to age in BRCA-1/2 mutated patients with recurrent platinum-sensitive ovarian cancer: Analysis of the phase III SOLO2 (AGO-OVAR 2.23/ENGOT-Ov21) study. |
|
|
Honoraria - AstraZeneca; Clovis Oncology; Roche; Tesaro |
Consulting or Advisory Role - AstraZeneca; Roche; Tesaro |
Research Funding - AstraZeneca; GlaxoSmithKline; Roche |
Travel, Accommodations, Expenses - AstraZeneca; Tesaro |
|
|
Honoraria - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Janssen-Cilag; Jenapharm; Medac; Novartis/Pfizer; PharmaMar; Roche/Genentech; Teva |
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Immunogen; Janssen-Cilag; Medac; Merck Sharp & Dohme; Roche; Sensor-Kinesis Corp.; Tesaro |
Research Funding - AstraZeneca; Bayer; Boehringer Ingelheim; GlaxoSmithKline; Janssen-Cilag; Medac; PharmaMar; Roche; Tesaro |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - AstraZeneca |
Speakers' Bureau - Clovis Oncology |
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); Immunogen (Inst); Lilly (Inst); Millennium (Inst); Pfizer (Inst) |
Travel, Accommodations, Expenses - AstraZeneca; Tesaro |
|
|
Honoraria - Abbvie; AstraZeneca; Clovis Oncology; Eisai; Genentech/Roche; Janssen; Merck; Newlink Genetics; Sutter Medical Group; Tesaro; Vascular Biogenics |
Consulting or Advisory Role - Abbvie; AstraZeneca; Clovis Oncology; Eisai; Janssen; Merck; Newlink Genetics; Roche/Genentech; Sutter Medical Group; Tesaro; Vascular Biogenics |
Research Funding - Array BioPharma; AstraZeneca; Eisai; Genentech; Merck; Regeneron; Sanofi; Tesaro; Vascular Biogenics |
Patents, Royalties, Other Intellectual Property - Blackwell Publishing Medicine at a glance; BMJ; UpToDate |
Travel, Accommodations, Expenses - AstraZeneca; Vascular Biogenics |
Other Relationship - Abbvie; AstraZeneca |
(OPTIONAL) Uncompensated Relationships - Care4ward |
|
|
|
Consulting or Advisory Role - Immunogen; Merck KGaA |
Research Funding - AstraZeneca (Inst); Immunovaccine (Inst) |
Travel, Accommodations, Expenses - AstraZeneca |
Other Relationship - AstraZeneca; Clovis Oncology; Clovis Oncology; Merck; Tesaro |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Speakers' Bureau - Clovis Oncology; MSD |
|
|
Honoraria - AstraZeneca; Lilly; MSD; Novartis; Takeda |
Consulting or Advisory Role - Abbvie; AstraZeneca; Lilly; MSD; Novartis; Takeda |
Speakers' Bureau - ACT Genomics; AstraZeneca |
Research Funding - AstraZeneca (Inst); BeiGene (Inst) |
Travel, Accommodations, Expenses - AstraZeneca |
|
|
Honoraria - AstraZeneca; PharmaMar; Roche/Genentech; Tesaro |
Consulting or Advisory Role - AstraZeneca; BioCad; Clovis Oncology; GlaxoSmithKline; MSD Oncology; Pfizer; PharmaMar; Roche/Genentech; Takeda; Tesaro |
|
|
Honoraria - Bayer; Chugai Pharma; Daiichi Sankyo; Daiichi Sankyo; Kyowa Hakko Kirin; Nippon Kayaku; Ono Pharmaceutical; Taiho Pharmaceutical; Zeria Pharmaceutical |
Consulting or Advisory Role - Eisai; MSD; Pfizer |
Research Funding - AstraZeneca (Inst); Eisai (Inst); Immunogen (Inst); Kaken Pharmaceutical (Inst); MSD (Inst); Oncotherapeutics (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst); Zeria Pharmaceutical (Inst) |
Travel, Accommodations, Expenses - Pfizer |
|
|
Consulting or Advisory Role - Novartis (Inst) |
Research Funding - AstraZeneca (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Roche (Inst) |
|
|
Consulting or Advisory Role - Amgen (Inst); AstraZeneca (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst); Tesaro (Inst) |
Research Funding - Roche (Inst) |
Travel, Accommodations, Expenses - AstraZeneca (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst); Teva (Inst) |
|
|
|
Stock and Other Ownership Interests - AstraZeneca |
|
|
Honoraria - AstraZeneca; GlaxoSmithKline; Tesaro |
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Incyte; Merck; Pfizer/EMD Serono; Roche; TESARO |
Travel, Accommodations, Expenses - AstraZeneca; Roche; Tesaro |
Other Relationship - Arcagy-Gineco |